News from

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2791 Results
Catching up with omicron
Microscopic view of numerous particles of SARS-CoV-2 labeled blue emerging from an infected cell.

Particles of SARS-CoV-2, the virus that causes COVID-19, emerged from a cell infected in a lab. Researchers and clinicians at Penn and around the world have turned their attention to omicron, a recently emerged variant that is sweeping through the population. (Image: National Institute of Allergy and Infectious Diseases)

Catching up with omicron

The Perelman School of Medicine’s Frederic Bushman and Susan Weiss share what they and other scientists are learning about the new, dominant variant of SARS-CoV-2.

Katherine Unger Baillie

A structural blueprint of nanoparticles to target acute lung inflammation
X-ray of lungs illuminated in red.

A structural blueprint of nanoparticles to target acute lung inflammation

Targeting neutrophils, a type of white blood cell that, when overactive, contributes to acute lung inflammation, is a potential new route to diagnose and treat acute respiratory distress syndrome.

From Penn Medicine News

From foundational discoveries to profound impact
weissman and kariko in the lab Today, Weissman and colleagues are working to develop a pan-coronavirus vaccine capable of protecting the population against SARS, MERS, SARS-CoV-2, and more. At BioNTech, Karikó is overseeing parallel but distinct research on a range of diseases in which patients receive mRNA encoding therapeutic proteins. (Image: Peggy Peterson)

From foundational discoveries to profound impact

How decades of mRNA research at Penn made powerful new COVID-19 vaccines possible—and opened a new vista for future discoveries.

Ashley Rabinovitch

The COVID landscape after a year with vaccines
Vials labeled "SARS-CoV-2 COVID-19 Vaccine" lit up with neon light on a machine filling them.

nocred

The COVID landscape after a year with vaccines

In a conversation hosted by LDI, experts from Penn, the Black Doctors COVID-19 Consortium, and the Coalition for Epidemic Preparedness Innovations discussed the vaccine rollout, boosters, misinformation, and more.

Michele W. Berger

In Peru and the U.S., considering the factors that drive public health
Michael Levy

Michael Z. Levy, whose own research uses interdisciplinary methods to shed light on epidemiology and public health, taught the course with colleague César Ugarte-Gil and featured a bevy of guest experts. (Image: Peggy Peterson)

In Peru and the U.S., considering the factors that drive public health

By comparing and contrasting the two nations’ approaches to controlling infectious diseases, students in Parallel Plagues deepened their appreciation of how these diseases emerge, cause harm, and might be effectively controlled.

Katherine Unger Baillie

Heart disease-protective diabetes drug is not used equitably
Doctor wearing a mask checks the blood pressure of a patient also wearing a mask.

Heart disease-protective diabetes drug is not used equitably

The medication GLP-1 RA treats diabetes and is linked to positive outcomes for heart disease patients, yet a Penn Medicine study has found inequities in its use along racial, ethnic, and economic lines

From Penn Medicine News

Hospitalizations for eating disorder increased during pandemic
A mostly eaten apple in front of a mirror showing a whole, uneaten apple.

Hospitalizations for eating disorder increased during pandemic

Researchers can’t yet pinpoint definitive reasons, though they surmise it was a combination of factors, including stress, an outsized focus on weight gain and personal appearance, and maybe even symptoms of COVID-19 itself.

Michele W. Berger

COVID-19 vaccine volunteers share their stories, one year later
preparing a shot at the vaccine clinic

nocred

COVID-19 vaccine volunteers share their stories, one year later

On the one-year anniversary of the COVID-19 vaccine authorizations, Penn Medicine highlights the volunteers who played a critical role in providing much needed hope, in addition to crucial data showing the safety and effectiveness of the vaccines.

From Penn Medicine News